Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.31
+0.12 (0.91%)
At close: Sep 5, 2025, 4:00 PM
13.22
-0.09 (-0.67%)
After-hours: Sep 5, 2025, 7:47 PM EDT
Avantor Revenue
Avantor had revenue of $1.68B in the quarter ending June 30, 2025, a decrease of -1.14%. This brings the company's revenue in the last twelve months to $6.67B, down -2.34% year-over-year. In the year 2024, Avantor had annual revenue of $6.78B, down -2.64%.
Revenue (ttm)
$6.67B
Revenue Growth
-2.34%
P/S Ratio
1.36
Revenue / Employee
$493,763
Employees
13,500
Market Cap
9.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.78B | -183.60M | -2.64% |
| Dec 31, 2023 | 6.97B | -545.20M | -7.26% |
| Dec 31, 2022 | 7.51B | 126.30M | 1.71% |
| Dec 31, 2021 | 7.39B | 992.50M | 15.52% |
| Dec 31, 2020 | 6.39B | 353.30M | 5.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
AVTR News
- 20 days ago - Engine Capital takes a stake in Avantor. Activist sees several ways to create value - CNBC
- 25 days ago - Avantor® Reiterates Shareholder Value Creation Focus - PRNewsWire
- 25 days ago - Activist investor Engine Capital urges Avantor to refresh board with new directors - Reuters
- 25 days ago - Engine Capital Sends Letter to Avantor's Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value - Business Wire
- 26 days ago - Engine Capital builds stake in Avantor, plans to push it to sell itself, WSJ reports - Reuters
- 26 days ago - Activist Investor to Push Avantor to Sell Itself - WSJ
- 5 weeks ago - Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure - Benzinga
- 5 weeks ago - Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript - Seeking Alpha